{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:29:41Z","timestamp":1790508581255,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":1104,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jchf.2014.08.005","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T16:08:32Z","timestamp":1422893312000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical Outcomes With Use of\u00a0Erythropoiesis Stimulating Agents in\u00a0Patients With\u00a0the\u00a0HeartMate II Left\u00a0Ventricular Assist Device"],"prefix":"10.1016","volume":"3","author":[{"given":"Michael E.","family":"Nassif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayendrakumar S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrica E.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Raymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ronald","family":"Jackups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Silvestry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane J.","family":"LaRue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2014.08.005_bib1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.105.582577","article-title":"Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program","volume":"113","author":"O'Meara","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.08.005_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejheart.2005.11.017","article-title":"Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction","volume":"8","author":"Valeur","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2014.08.005_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2004.05.070","article-title":"Anemia as a risk factor and therapeutic target in heart failure","volume":"44","author":"Felker","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2014.08.005_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2014.08.005_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2014.08.005_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1751-7133.2008.00030.x","article-title":"The impact of anemia on the\u00a0prognosis of chronic heart failure: a meta-analysis and systemic review","volume":"15","author":"He","year":"2009","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jchf.2014.08.005_bib7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2014.08.005_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ahj.2004.08.039","article-title":"Prevalence of anemia and effects on mortality in patients with heart failure","volume":"149","author":"Lindenfeld","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2014.08.005_bib9","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/eurjhf\/hfp110","article-title":"Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support","volume":"11","author":"Vrtovec","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2014.08.005_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1191\/0267659105pf793oa","article-title":"Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device","volume":"20","author":"Pierce","year":"2005","journal-title":"Perfusion"},{"key":"10.1016\/j.jchf.2014.08.005_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1051\/ject\/200436110","article-title":"Inflammatory mediated chronic anemia in patients supported with a mechanical circulatory assist device","volume":"36","author":"Pierce","year":"2004","journal-title":"J\u00a0Extra Corpor Technol"},{"key":"10.1016\/j.jchf.2014.08.005_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002480-200105000-00023","article-title":"Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device","volume":"47","author":"Loebe","year":"2001","journal-title":"ASAIO J"},{"key":"10.1016\/j.jchf.2014.08.005_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1540-8191.2006.00241.x","article-title":"Does the use of erythropoietin reduce the risk of\u00a0exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis","volume":"21","author":"Alghamdi","year":"2006","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.jchf.2014.08.005_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1067\/mtc.2001.115426","article-title":"Recombinant human erythropoietin administration in cardiac surgery","volume":"122","author":"Yazicioglu","year":"2001","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jchf.2014.08.005_bib15","first-page":"78","article-title":"Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management","volume":"33","author":"Messmer","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jchf.2014.08.005_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jtcvs.2009.10.012","article-title":"Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study","volume":"139","author":"Weltert","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jchf.2014.08.005_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.trre.2009.07.001","article-title":"Management of allosensitized cardiac transplant candidates","volume":"23","author":"Velez","year":"2009","journal-title":"Transplant Rev"},{"key":"10.1016\/j.jchf.2014.08.005_bib18","series-title":"Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update","author":"Grant","year":"2013"},{"key":"10.1016\/j.jchf.2014.08.005_bib19","first-page":"CD003407","article-title":"Erythropoietin or darbepoetin for patients with cancer","volume":"12","author":"Tonia","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jchf.2014.08.005_bib20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.08.005_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.08.005_bib22","series-title":"Public Health Advisory: Erythropoiesis-Stimulating Agents (ESAs)","author":"Klein","year":"2009"},{"issue":"Suppl 1","key":"10.1016\/j.jchf.2014.08.005_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/bjoc.2001.1748","article-title":"A\u00a0dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy","volume":"84","author":"Glaspy","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jchf.2014.08.005_bib24","unstructured":"Aranesp(R) [package insert]. Thousand Oaks, CA: Amgen Pharmaceuticals Inc,\u00a02010. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/darbamg071902lb.pdf. Accessed September 2013."},{"key":"10.1016\/j.jchf.2014.08.005_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jchf.2014.08.005_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1525-1594.2001.06770.x","article-title":"The Heartmate II: design and development of a fully sealed axial flow left ventricular assist system","volume":"25","author":"Burke","year":"2001","journal-title":"Art Organs"},{"key":"10.1016\/j.jchf.2014.08.005_bib27","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/S0003-4975(00)02639-4","article-title":"HeartMate II left ventricular assist system: from concept to first clinical use","volume":"71","author":"Griffith","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jchf.2014.08.005_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.08.005_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2013.05.002","article-title":"Algorithm for the diagnosis and management of suspected pump thrombus","volume":"32","author":"Goldstein","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2014.08.005_bib30","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jacc.2012.07.052","article-title":"Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study","volume":"60","author":"Uriel","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2014.08.005_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.healun.2013.07.013","article-title":"Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support","volume":"33","author":"Shah","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2014.08.005_bib32","first-page":"CD007613","article-title":"Erythropoiesis-stimulating agents for anaemia in\u00a0chronic\u00a0heart failure patients","author":"Ngo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jchf.2014.08.005_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1255448","article-title":"Thrombotic complications of erythropoiesis-stimulating agents","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jchf.2014.08.005_bib34","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2004121039","article-title":"Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease","volume":"16","author":"Parfrey","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2014.08.005_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.ajkd.2012.07.014","article-title":"Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis","volume":"61","author":"Koulouridis","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jchf.2014.08.005_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease\u00a0who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2014.08.005_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2014.08.005_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.healun.2013.11.001","article-title":"Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device","volume":"33","author":"Kirklin","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2014.08.005_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2012.09.055","article-title":"Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score","volume":"61","author":"Cowger","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914004739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177914004739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:49:23Z","timestamp":1717703363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177914004739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213177914004739"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2014.08.005","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes With Use of\u00a0Erythropoiesis Stimulating Agents in\u00a0Patients With\u00a0the\u00a0HeartMate II Left\u00a0Ventricular Assist Device","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}